CoChat

In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments

Christophersen, Lars, Schwartz, Franziska Angelika, Lerche, Christian Johann, Svanekjær, Trine, Kragh, Kasper Nørskov, Laulund, Anne Sofie, Thomsen, Kim, Henneberg, Kaj-Åge, Sams, Thomas, Høiby, Niels, Moser, Claus · 2020 · Journal of Cystic Fibrosis
Cited by 24

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcf.2020.01.009

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 33

  1. Skov, 2019, Cystic fibrosis – an example of personalized and precision medicine, APMIS, 127, 352, 10.1111/apm.12915 · DOI
  2. Høiby, 2017, Diagnosis of biofilm infections in cystic fibrosis patients, APMIS, 125, 339, 10.1111/apm.12689 · DOI
  3. Høiby, 2015, ESCMID guideline for the diagnosis and treatment of biofilm infections 2014, Clin Microbiol Infect, 21, S1, 10.1016/j.cmi.2014.10.024 · DOI · Paper page
  4. Høiby, 2010, Antibiotic resistance of bacterial biofilms, Int J Antimicrob Agents, 35, 322, 10.1016/j.ijantimicag.2009.12.011 · DOI · Paper page
  5. Kragh, 2014, Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients, Infect Immun, 82, 4477, 10.1128/IAI.01969-14 · DOI · Paper page
  6. Chiang, 2013, Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, 57, 2352, 10.1128/AAC.00001-13 · DOI · Paper page
  7. Pamp, 2008, Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes, Mol Microbiol, 10.1111/j.1365-2958.2008.06152.x · DOI · Paper page
  8. Bagge, 2004, Pseudomonas aeruginosa biofilms exposed to imipenem exhibit changes in global gene expression and β-Lactamase and alginate production, Antimicrob Agents Chemother, 10.1128/AAC.48.4.1175-1187.2004 · DOI · Paper page
  9. Zimmerli, 2012, Pathogenesis and treatment concepts of orthopaedic biofilm infections, FEMS Immunol Med Microbiol, 65, 158, 10.1111/j.1574-695X.2012.00938.x · DOI · Paper page
  10. Cao, 2015, Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model, J Antimicrob Chemother, 70, 2057, 10.1093/jac/dkv058 · DOI · Paper page
  11. Cao, 2016, Diffusion retardation by binding of tobramycin in an alginate biofilm model, PLoS One, 11
  12. Pedersen, 1990, Induction of experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa entrapped in alginate microspheres, APMIS, 10.1111/j.1699-0463.1990.tb01023.x · DOI · Paper page
  13. Christophersen, 2012, Bead-size directed distribution of Pseudomonas aeruginosa results in distinct inflammatory response in a mouse model of chronic lung infection, Clin Exp Immunol, 170, 222, 10.1111/j.1365-2249.2012.04652.x · DOI
  14. Gade, 2018, Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms, PLoS One, 13, 1, 10.1371/journal.pone.0198909 · DOI · Paper page
  15. Nichols, 1988, Inhibition of tobramycin diffusion by binding to alginate, Antimicrob Agents Chemother, 32, 518, 10.1128/AAC.32.4.518 · DOI · Paper page
  16. Skeel, 1990, A method for the spatial discretization of parabolic equations in one space variable, SIAM J Sci Stat Comput, 1, 10.1137/0911001 · doi:10.1137/0911001
  17. Moser, 2017, Biofilms and host response - helpful or harmful, APMIS, 125, 320, 10.1111/apm.12674 · DOI · Paper page
  18. Herrmann, 2010, Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa, J Infect Dis, 202, 1585, 10.1086/656788 · DOI · Paper page
  19. Fernández-Barat, 2017, Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment, J Cyst Fibros, 16, 222, 10.1016/j.jcf.2016.08.005 · DOI · Paper page
  20. Burns, 1999, Intermittent administration of inhaled tobramycin in patients with cystic fibrosis, J Infect Dis, 179, 1190, 10.1086/314727 · DOI · Paper page
  21. Müsken, 2018, Breaking the vicious cycle of antibiotic killing and regrowth of biofilm-residing pseudomonas aeruginosa, Antimicrob Agents Chemother, 62, 10.1128/AAC.01635-18 · DOI
  22. van Gennip, 2009, Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa, J Antimicrob Chemother, 64, 1241, 10.1093/jac/dkp352 · DOI
  23. Stewart, 2002, Mechanisms of antibiotic resistance in bacterial biofilms, Int J Med Microbiol, 292, 107, 10.1078/1438-4221-00196 · DOI · Paper page
  24. Suci, 1994, Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms, Antimicrob Agents Chemother, 38, 2125, 10.1128/AAC.38.9.2125 · DOI · Paper page
  25. Stewart, 2009, Daptomycin rapidly penetrates a Staphylococcus epidermidis biofilm, Antimicrob Agents Chemother, 53, 3505, 10.1128/AAC.01728-08 · DOI · Paper page
  26. Müller, 2018, Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin, J Antimicrob Chemother, 73, 2762, 10.1093/jac/dky241 · DOI
  27. Sønderholm, 2017, Aggregate formation of Pseudomonas aeruginosa in an alginate bead model system exhibits in vivo like characteristics, Appl Environ Microbiol, 10.1128/AEM.00113-17 · DOI · Paper page
  28. Sønderholm, 2018, Tools for studying growth patterns and chemical dynamics of aggregated Pseudomonas aeruginosa exposed to different electron acceptors in an alginate bead model, Npj Biofilms Microbiomes, 10.1038/s41522-018-0047-4 · DOI · Paper page
  29. Hengzhuang, 2016, OligoG CF-5/20 disruption of mucoid Pseudomonas aeruginosa biofilm in a murine lung infection model, Antimicrob Agents Chemother, 60, 2620, 10.1128/AAC.01721-15 · DOI
  30. Tavafi, 2018, Screening, cloning and expression of a novel alginate lyase gene from P. aeruginosa TAG 48 and its antibiofilm effects on P. aeruginosa biofilm, Microb Pathog, 124, 356, 10.1016/j.micpath.2018.08.018 · DOI
  31. Heilesen, 1983, Treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients with Ceftazidime and Tobramycin, Scand J Infect Dis, 13, 271, 10.3109/inf.1983.15.issue-3.07 · DOI
  32. Arai, 2014, Enzymatic characterization and in vivo function of five terminal oxidases in Pseudomonas aeruginosa, J Bacteriol, 196, 4206, 10.1128/JB.02176-14 · DOI · Paper page
  33. Han, 1996, Temperature dependence of oxygen diffusion in H2O and D2O, J Phys Chem, 100, 10.1021/jp952903y · DOI · Paper page

Cited by

See all 24

Metadata

Authors
Christophersen, L., Schwartz, F. A., Lerche, C. J., Svanekjær, T., Kragh, K. N., Laulund, A. S., Thomsen, K., Henneberg, K.-Å., Sams, T., Høiby, N., & Moser, C.
Venue
Journal of Cystic Fibrosis
Publisher
Elsevier BV
Published
2020-11
Volume
19
Issue
6
Pages
996-1003
ISSN
1569-1993
Cited by
24
References
2
Language
en
Licence
Funders
Novo Nordisk Fonden (NNF17OC0025074)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments. https://app.cochat.ai/papers/10.1016/j.jcf.2020.01.009
The paper
Christophersen, L., Schwartz, F. A., Lerche, C. J., Svanekjær, T., Kragh, K. N., Laulund, A. S., Thomsen, K., Henneberg, K.-Å., Sams, T., Høiby, N., & Moser, C. (2020). In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2020.01.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.